Koch Research is investigating potential therapies for managing CKD and cardiovascular conditions.
Don't Let CKD Steal Your Heart Health
Chronic kidney disease (CKD) encompasses more than waste removal challenges, extending to systemic inflammation marked by elevated C-reactive protein (CRP) levels. This inflammatory state contributes to vascular damage and arterial plaque formation, substantially elevating the risk of cardiovascular events such as heart attacks and strokes among CKD patients.
Clinical Trials for Kidney Disease are advancing medical knowledge and improving patient outcomes. Participating in kidney disease and cardiovascular clinical trials allows you to contribute to developing new medications, treatment approaches, and lifestyle interventions aimed at managing CKD and reducing cardiovascular risk.
Risk Factors
- Hypertension
- Diabetes
- Smoking
- Dyslipidemia
- Obesity
Disclaimer
**Participation in the study, including all procedures and treatment including the investigational drug, is provided at no cost, and having insurance is not required**
Enroll Now!
Interested in participating in a clinical trial?
Clinical Trials for Kidney Disease
Nephrology Clinical Trials aim to investigate the safety and tolerability of a novel drug in patients with chronic kidney disease and elevated CRP levels. By assessing the safety and tolerability of this new drug, researchers seek to discover potential benefits for managing chronic kidney disease and advancing Nephrology Research.
Eligibility Criteria
- Age :18 Years and older
- Gender : Male & Female
- Condition : Chronic Kidney Disease
- Total Studies : 01
- Status : Recruiting
Understanding Chronic Kidney Disease (CKD)
Chronic kidney disease (CKD) refers to a gradual decline in kidney function over time. While its primary role is to filter waste products from the blood, healthy kidneys also play a vital role in regulating blood pressure and hormone production. Studies suggest that over 10% of the worldwide population, or more than 800 million individuals, are affected by CKD
In CKD, these functions become compromised, leading to a buildup of toxins and imbalances in the body. This can have a significant impact on cardiovascular health. Uncontrolled blood pressure and hormonal imbalances are established risk factors for heart disease and stroke, making CKD patients more susceptible to these complications. Kidney disease and cardiovascular clinical trials are one of the potential treatments to manage this condition
Frequently Asked Questions
What are the symptoms of CKD?
Early stages often have no symptoms. Later, fatigue, high blood pressure, blood in urine, and swelling in ankles or feet may occur.
Am I at risk for CKD?
Yes, if you have diabetes, high blood pressure, a family history of CKD, or are overweight.
Are there risks involved in participating in a kidney disease clinical trial?
Like any medical intervention, clinical trials for kidney disease may involve risks. These risks can vary depending on the specific trial and treatment being studied.
What types of conditions are studied in kidney disease and cardiovascular clinical trials?
Clinical trials for cardiovascular health may focus on various conditions, including heart disease, hypertension, and heart failure. While, in nephrology CKD, AKI, PDI, and others are studied.
